Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial
Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- A case report of advanced small intestinal stromal tumor with KIT gene mutation and BRCA2 deletion after multi-line treatments
- Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
- Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
- UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)